Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05512247
Other study ID # IRB-300009764
Secondary ID P50MD017338
Status Recruiting
Phase N/A
First received
Last updated
Start date October 5, 2023
Est. completion date December 31, 2025

Study information

Verified date January 2024
Source University of Alabama at Birmingham
Contact Camille S Worthington, PhD
Phone 205-975-7274
Email cschneid@uab.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is being done to assess the feasibility, acceptability, and preliminary impact of a meal delivery intervention designed to improve diet quality and promote appropriate gestational weight gain among predominantly Black and low-income pregnant women with overweight or obesity. This will be done by 1) assessing the feasibility and acceptability of the meal delivery intervention; 2) investigating changes in patient-reported diet quality, barriers to healthy eating, and food security; and 3) exploring the preliminary impact of the meal delivery intervention on gestational weight gain and blood pressure and estimate the effect size of the intervention relative to a de-identified non-randomized control group that will be derived from de-identified hospital records.


Description:

Subjects will receive 10 home-delivered meals per week from about 20 weeks gestation until 40 weeks gestation.


Recruitment information / eligibility

Status Recruiting
Enrollment 18
Est. completion date December 31, 2025
Est. primary completion date December 31, 2024
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - Medicaid eligible and/or have a household income at or below 185 percent of the federal poverty line - 18 years of age or older - <= 19 weeks gestation - Currently experiencing a singleton pregnancy - Receiving prenatal care at a University of Alabama at Birmingham clinic - Planning to deliver at the University of Alabama at Birmingham - Residing within the meal company's delivery radius - Body mass index >= 25 - Willing to consent Exclusion Criteria: - Self-reported major health condition (such as renal disease, cancer, or Type 1 or Type 2 diabetes) - Current treatment for severe psychiatric disorder (such as schizophrenia) - Current substance abuse - Self-reported diagnosis of anorexia or bulimia - Known fetal anomaly - Current use of medication expected to significantly impact body weight - Planned termination of the current pregnancy - Participation in another dietary and/or weight management intervention during the current pregnancy - Unwilling or unable to understand and communicate in English - Unwilling or unable to consume study meals

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Meal Delivery
10 home-delivered meals per week provided by a local meal delivery company + brief weekly behavioral support with study staff

Locations

Country Name City State
United States University of Alabama at Birmingham Birmingham Alabama

Sponsors (2)

Lead Sponsor Collaborator
University of Alabama at Birmingham National Institute on Minority Health and Health Disparities (NIMHD)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Change in Blood Pressure Systolic and diastolic blood pressure measured at each prenatal visit will be retrieved from medical records for all participants at the end of the intervention. First prenatal visit through delivery (Collected once at study end from medical record)
Other Gestational weight gain Weight measured at each prenatal visit will be retrieved from medical records for all participants at the end of the intervention and used to calculate total gestational weight gain and rate of gestational weight gain. First prenatal visit through delivery (Collected once at study end from medical record)
Primary Change in Healthy Eating Index score from baseline to follow-up Determined based on the Healthy Index Score, in which 100 indicates complete alignment with the Dietary Guidelines for Americans and 0 is the minimum score, as calculated from three 24-hour dietary recalls conducted on non-consecutive days (2 weekdays + 1 weekend day) at each time point. three 24-hour dietary recalls on non-consecutive days at baseline (18-22 weeks gestation) and follow-up (33-37 weeks gestation)
Secondary Change in Food Security Determined using the 18-item United States (US) Household Food Security Survey Module based on the previous 30 days. Adult food security scores range from 0 to 10, with lower values indicating greater food security. baseline (18-22 weeks gestation), (33-37 weeks gestation)
Secondary Change in Barriers to Healthy Eating Participants will be asked to score 5 statements corresponding to different barriers to healthy eating on a 5-point Likert scale ranging from strongly agree to strongly disagree (adapted from Sibai D et al. 2022). Changes in the distribution of responses to each barrier will be assessed, as well as changes in the proportion of women somewhat/strongly agreeing with each barrier will be compared. baseline (18-22 weeks gestation), follow-up (33-37 weeks gestation)
Secondary Study Participation Rate Percentage of eligible subjects who agreed to participate out of those who were screened. baseline (18-22 weeks gestation)
Secondary Participant Retention The proportion of enrolled participants who complete follow-up baseline (18-22 weeks gestation), follow-up (33-37 weeks gestation)
Secondary Participant Adherence to Intervention Proportion of weekly study meals participants consumed based on responses to weekly electronic surveys in which participants will report the number of study meals a) they consumed, b) other household members consumed, or c) that were uneaten. Collected weekly from intervention start (20-24 weeks gestation) to intervention end (40 weeks gestation)
Secondary Change in Participant Satisfaction with Diet To assess satisfaction with the study intervention, the 28-item Diet Satisfaction Questionnaire will be used in which participants respond to 28 statements using a 5-point Likert scale. Responses are average to produce a total diet satisfaction score ranging from 1-5. Changes in overall diet satisfaction, as well as changes in subscale scores for Cost Factor and Planning & Preparation Factor will be examined from baseline to follow-up. baseline (18-22 weeks gestation), follow-up (33-37 weeks gestation)
See also
  Status Clinical Trial Phase
Completed NCT03442582 - Afluria Pregnancy Registry
Terminated NCT02161861 - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study N/A
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Enrolling by invitation NCT05415371 - Persistent Poverty Counties Pregnant Women With Medicaid N/A
Completed NCT04548102 - Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman N/A
Completed NCT03218956 - Protein Requirement During Lactation N/A
Completed NCT02191605 - Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy N/A
Completed NCT02223637 - Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
Recruiting NCT06049953 - Maternal And Infant Antipsychotic Study
Completed NCT02577536 - PregSource: Crowdsourcing to Understand Pregnancy
Not yet recruiting NCT06336434 - CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy Phase 1/Phase 2
Not yet recruiting NCT05412238 - Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months N/A
Not yet recruiting NCT04786587 - Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
Not yet recruiting NCT05028387 - Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
Completed NCT02783170 - Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women Phase 4
Completed NCT02683005 - Study of Hepatitis C Treatment During Pregnancy Phase 1
Recruiting NCT02619188 - Nutritional Markers in Normal and Hyperemesis Pregnancies N/A
Recruiting NCT02564250 - Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women N/A
Recruiting NCT02507180 - Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
Completed NCT02379728 - Ghana PrenaBelt Trial: A Positional Therapy Device to Reduce Still-Birth N/A